Literature DB >> 20028396

How much binding affinity can be gained by filling a cavity?

Yuko Kawasaki1, Eduardo E Chufan, Virginie Lafont, Koushi Hidaka, Yoshiaki Kiso, L Mario Amzel, Ernesto Freire.   

Abstract

Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH(3)) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH(3))(2)]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028396      PMCID: PMC3209665          DOI: 10.1111/j.1747-0285.2009.00921.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  40 in total

Review 1.  HIV-1 protease: mechanism and drug discovery.

Authors:  Ashraf Brik; Chi-Huey Wong
Journal:  Org Biomol Chem       Date:  2003-01-07       Impact factor: 3.876

2.  Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.

Authors:  Hiroyasu Ohtaka; Adrian Velázquez-Campoy; Dong Xie; Ernesto Freire
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

3.  Hydrophobic packing in T4 lysozyme probed by cavity-filling mutants.

Authors:  M Karpusas; W A Baase; M Matsumura; B W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin II.

Authors:  Aiko Kiso; Koushi Hidaka; Tooru Kimura; Yoshio Hayashi; Azin Nezami; Ernesto Freire; Yoshiaki Kiso
Journal:  J Pept Sci       Date:  2004-11       Impact factor: 1.905

5.  Overcoming roadblocks in lead optimization: a thermodynamic perspective.

Authors:  Adam J Ruben; Yoshiaki Kiso; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2006-01       Impact factor: 2.817

6.  Isothermal titration calorimetry: controlling binding forces in lead optimization.

Authors:  Ernesto Freire
Journal:  Drug Discov Today Technol       Date:  2004-12

7.  2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.

Authors:  A O Koren; A G Horti; A G Mukhin; D Gündisch; A S Kimes; R F Dannals; E D London
Journal:  J Med Chem       Date:  1998-09-10       Impact factor: 7.446

8.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

9.  Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.

Authors:  Evan T Brower; Usman M Bacha; Yuko Kawasaki; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2008-02-28       Impact factor: 2.817

10.  The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

Authors:  A M Mildner; D J Rothrock; J W Leone; C A Bannow; J M Lull; I M Reardon; J L Sarcich; W J Howe; C S Tomich; C W Smith
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

View more
  16 in total

Review 1.  Finding a better path to drug selectivity.

Authors:  Yuko Kawasaki; Ernesto Freire
Journal:  Drug Discov Today       Date:  2011-08-02       Impact factor: 7.851

2.  Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function.

Authors:  Jay Chauhan; Shen-En Chen; Katherine J Fenstermacher; Aurash Naser-Tavakolian; Tali Reingewertz; Rosene Salmo; Christian Lee; Emori Williams; Mithun Raje; Eric Sundberg; Jeffrey J DeStefano; Ernesto Freire; Steven Fletcher
Journal:  Bioorg Med Chem       Date:  2015-09-07       Impact factor: 3.641

3.  Ligand binding analysis and screening by chemical denaturation shift.

Authors:  Arne Schön; Richard K Brown; Burleigh M Hutchins; Ernesto Freire
Journal:  Anal Biochem       Date:  2013-08-29       Impact factor: 3.365

4.  Protein-ligand interactions: probing the energetics of a putative cation-π interaction.

Authors:  James M Myslinski; John H Clements; Stephen F Martin
Journal:  Bioorg Med Chem Lett       Date:  2014-05-09       Impact factor: 2.823

5.  Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing.

Authors:  Jonathan L Chen; Peiyuan Zhang; Masahito Abe; Haruo Aikawa; Liying Zhang; Alexander J Frank; Timothy Zembryski; Christopher Hubbs; HaJeung Park; Jane Withka; Claire Steppan; Lucy Rogers; Shawn Cabral; Martin Pettersson; Travis T Wager; Matthew A Fountain; Gavin Rumbaugh; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2020-05-04       Impact factor: 15.419

6.  A detailed thermodynamic profile of cyclopentyl and isopropyl derivatives binding to CK2 kinase.

Authors:  Takayoshi Kinoshita; Yusuke Sekiguchi; Harumi Fukada; Tetsuko Nakaniwa; Toshiji Tada; Shinya Nakamura; Kazuo Kitaura; Hiroaki Ohno; Yamato Suzuki; Akira Hirasawa; Isao Nakanishi; Gozoh Tsujimoto
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

7.  Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation.

Authors:  Thomas P Smith; Ian W Windsor; Katrina T Forest; Ronald T Raines
Journal:  J Med Chem       Date:  2017-09-18       Impact factor: 7.446

8.  Enthalpy screen of drug candidates.

Authors:  Arne Schön; Ernesto Freire
Journal:  Anal Biochem       Date:  2016-08-25       Impact factor: 3.365

9.  Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein.

Authors:  Laurence Morellato-Castillo; Priyamvada Acharya; Olivier Combes; Johan Michiels; Anne Descours; Oscar H P Ramos; Yongping Yang; Guido Vanham; Kevin K Ariën; Peter D Kwong; Loïc Martin; Pascal Kessler
Journal:  J Med Chem       Date:  2013-06-11       Impact factor: 7.446

10.  Protein-Ligand Interactions: Thermodynamic Effects Associated with Increasing the Length of an Alkyl Chain.

Authors:  James M Myslinski; John H Clements; John E Delorbe; Stephen F Martin
Journal:  ACS Med Chem Lett       Date:  2013-11-14       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.